A whistleblower, supported by leaked internal documents, alleges that Australia’s medical regulator overlooks serious concerns about a homegrown defibrillator that is supplied for use by ambulance services. Multiple reports say the device’s testing and evaluation raise questions, including claims that testing involved pigs and that resulting data were flawed or incomplete. The whistleblower claims red flags were identified during assessment but were not properly addressed, and that the defibrillator is still approved or provided to ambulance officers despite the concerns. The reports describe the dispute as one involving regulatory oversight and the adequacy of evidence used to support the device’s performance and safety. While the accounts agree on the core allegations—whistleblower involvement, leaked documents, and concerns about the testing validity—the reports focus on different aspects of the underlying evidence rather than providing a single unified technical conclusion. The regulator and other relevant parties are not stated as agreeing with the allegations in the provided summaries, and no definitive findings are described beyond the whistleblower’s claims and the circulation of internal materials.